Free Trial

Tilray Brands (TLRY) Competitors

C$2.45
-0.03 (-1.21%)
(As of 05/31/2024 ET)

TLRY vs. APHA, BHC, CRON, THCX, WEED, GUD, ACB, FIRE, CRDL, and OGI

Should you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include Aphria (APHA), Bausch Health Companies (BHC), Cronos Group (CRON), Hydropothecary (THCX), Canopy Growth (WEED), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Supreme Cannabis (FIRE), Cardiol Therapeutics (CRDL), and Organigram (OGI). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Tilray Brands vs.

Tilray Brands (TSE:TLRY) and Aphria (TSE:APHA) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, community ranking, analyst recommendations and risk.

Aphria received 381 more outperform votes than Tilray Brands when rated by MarketBeat users. Likewise, 68.04% of users gave Aphria an outperform vote while only 0.00% of users gave Tilray Brands an outperform vote.

CompanyUnderperformOutperform
Tilray BrandsOutperform Votes
No Votes
Underperform Votes
7
100.00%
AphriaOutperform Votes
381
68.04%
Underperform Votes
179
31.96%

12.2% of Tilray Brands shares are held by institutional investors. 1.2% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Tilray Brands' average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company Overall Sentiment
Tilray Brands Neutral
Aphria Neutral

Tilray Brands currently has a consensus price target of C$2.95, indicating a potential upside of 20.41%.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Aphria
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Tilray Brands has higher revenue and earnings than Aphria. Tilray Brands is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray BrandsC$743.25M2.72-C$351.95M-C$0.60-4.08
AphriaC$611.06M0.00-C$637.39M-C$2.01N/A

Aphria has a net margin of 0.00% compared to Tilray Brands' net margin of -47.35%. Aphria's return on equity of 0.00% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-47.35% -9.69% -1.67%
Aphria N/A N/A N/A

Summary

Tilray Brands beats Aphria on 6 of the 11 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilray BrandsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$2.02BC$1.19BC$5.16BC$5.45B
Dividend YieldN/A3.07%2.75%5.58%
P/E Ratio-4.08545.16105.2420.78
Price / Sales2.729,249.212,386.092,548.93
Price / Cash5.9510.4335.3879.75
Price / Book0.568.195.543.54
Net Income-C$351.95MC$159.95MC$106.07MC$287.78M
7 Day Performance-2.78%0.11%1.14%-0.16%
1 Month Performance-11.55%-0.77%0.69%2.59%
1 Year Performance4.70%35.89%2.66%29.05%

Tilray Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APHA
Aphria
0 of 5 stars
N/AN/AN/AC$5.24BC$611.06M-8.231,200
BHC
Bausch Health Companies
0.2136 of 5 stars
C$8.95
+4.2%
C$9.00
+0.6%
-18.9%C$3.28BC$8.97B-5.3020,270High Trading Volume
CRON
Cronos Group
0 of 5 stars
C$3.54
+3.5%
C$3.18
-10.2%
+51.3%C$1.35BC$93.03M-18.63356
THCX
Hydropothecary
0 of 5 stars
C$5.30
+6.6%
N/A+0.0%C$949.11MN/A0.00N/AHigh Trading Volume
WEED
Canopy Growth
0.0399 of 5 stars
C$11.59
-1.6%
C$3.78
-67.4%
+916.7%C$869.83MC$362.24M-0.542,700Analyst Forecast
GUD
Knight Therapeutics
0.8156 of 5 stars
C$6.00
+3.6%
C$6.75
+12.5%
+22.2%C$608.28MC$332.21M-37.50725High Trading Volume
ACB
Aurora Cannabis
0.0797 of 5 stars
C$8.42
-0.5%
C$2.26
-73.1%
+1,156.7%C$459.23MC$275.88M-0.111,130
FIRE
Supreme Cannabis
0 of 5 stars
N/AN/AN/AC$259.40MC$53.29M-10.97400
CRDL
Cardiol Therapeutics
0 of 5 stars
C$3.57
+1.1%
N/A+296.7%C$246.33MN/A-7.60N/A
OGI
Organigram
2.9467 of 5 stars
C$2.34
-0.4%
C$3.76
+60.6%
+358.8%C$241.02MC$149.21M-0.93984

Related Companies and Tools

This page (TSE:TLRY) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners